Home > Healthcare & Medical Devices > Breast Milk Substitutes Market
Breast Milk Substitutes Market size surpassed USD 73 billion in 2022 and is poised to depict over 9.5% CAGR through 2023-2032, on account of the increasing labor participation of women.
To get more details on this report: Request Free Sample PDF
With the economic boom and ease in access to education, the working women population continues to rise. Several initiatives have also been launched to encourage women’s employment. For instance, Japan has introduced wide-ranging campaigns to boost the labor force contribution of women. Additionally, the government took key measures to ensure daycare subsidization, increase allowances for new parents, and provide paid parental leaves. Such initiatives will promote the adoption of suitable alternatives to breast milk among working women worldwide, to provide adequate nutrition to their babies without hassle.
|Market Size in 2022:||USD 73.09 Billion|
|Forecast Period:||2023 to 2032|
|Forecast Period 2023 to 2032 CAGR:||9.7%|
|2032 Value Projection:||USD 184.86 Billion|
|Historical Data for:||2018 to 2022|
|No. of Pages:||150|
|Tables, Charts & Figures:||100|
|Segments covered:||Substitute, Formula, Distribution Channel, and Region|
|Pitfalls & Challenges:|
To get details on how to order this report click here
Despite the favorable business landscape, stringent norms associated with the marketing of breast milk substitutes have been introduced. Childhood obesity has also emerged as a concerning factor of malnutrition that poses lifelong health risks. Moreover, the rising awareness of the health consequences of breast milk replacement may assert an adverse impact on product sales. However, the growing service sector and high cost of living will encourage the work participation of women and consequently create opportunities for industry growth over the estimated timeline.
To tailor this report to your specific requirements: Customize this Report
Breast milk substitutes market share from the hypoallergenic formula substitute segment is slated to register over 9% CAGR through 2032, due to the rising prevalence of food allergies, eczema, and asthma. This factor has shifted consumer preference toward hypoallergenic formulas to prevent atopic diseases among infants. This protein hydrolysate breast milk substitute is also recommended for consumers who are unable to tolerate soy and cow milk-based formulas, further promoting product usage.
The industry value from the powdered formula segment is projected to cross USD 85 billion by 2032, given its long shelf life and cost-effectiveness as compared to ready-to-use and concentrated liquid counterparts. However, powdered milk formula may contain bacteria, making it risky for consumption by infants less than two months of age. Despite these potential risks, powdered infant formulas are recommended to avoid nutrition-related diseases in infants during their early growth stages, thus accelerating their sales worldwide.
To check discounted pricing for this report: Request Discount
Breast milk substitutes market from the pharmacies distribution channel is expected to depict a 9.5% CAGR through 2023-2032. Stringent regulations regarding infant product distribution and breast milk substitute promotional measures are some of the prominent drivers for product sales from pharmacies. Varied policies have also been introduced to promote the use of infant formulas, further bolstering breast milk substitute demand across pharmacy chains.
On the regional front, the Asia Pacific breast milk substitutes market size is anticipated to be worth over USD 81 billion by 2032. This is due to the increasing financial support from private and public organizations to boost awareness of breast milk substitutes. In Southeast Asia, the female employment participation rate is also higher than the global average, mainly due to cultural transformations over the past 40 years. These factors, alongside the strong focus of regional companies on capturing high market share, will contribute to breast milk alternative production across the region.
The competitive landscape of the breast milk substitutes market comprises companies such as The Kraft Heinz Company, Hyproca, Fonterra Co-operative Group, Mead Johnson & Company, LLC (Reckitt Benckiser), Vitagermine SAS, Nestle, Danone Nutricia, Abbott Nutrition, and FrieslandCampina, among others. These companies are incorporating product launches and other strategies to expand their foothold across the industry.
For instance, in September 2022, Nestle introduced Nutrilearn Connect, an infant formula, in Hong Kong. This product was developed with a novel ingredient, myelin, to protect and insulate nerve fibers for cognitive and behavioral development of infants. This strategy was meant to offer growth opportunities and allow the company to establish a strong presence in the market.
The coronavirus pandemic created a public health crisis and multiple social disruptions, thereby posing a negative impact on global industry verticals, including breast milk substitutes. However, the global birth rate has been surging significantly over recent years. Based on researchers at the University of Michigan Health Organization, the number of births will likely increase over the years ahead. This, along with the gradual ease of restrictions and normalization of supply chains, will generate opportunities for breast milk alternative producers to expand their businesses during the pandemic.
The breast milk substitutes market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments: Click here to buy sections of this report
Click here to buy sections of this report
By Distribution Channel
The above information is provided for the following regions and countries: